Align Technology, Inc. (ALGN)

Market Cap	12.16B -0.5%
Revenue (ttm)	4.03B +0.9%
Net Income	410.35M -2.6%
EPS	5.65 +0.5%
Shares Out	71.28M
PE Ratio	30.19
Forward PE	15.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,081,409
Open	168.52
Previous Close	172.73
Day's Range	164.00 - 175.15
52-Week Range	122.00 - 208.31
Beta	1.81
Analysts	Buy
Price Target	192.40 (+12.78%)
Earnings Date	Apr 29, 2026

About ALGN

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. T...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 20,290
• Stock Exchange: NASDAQ
• Ticker Symbol: ALGN
• Website: https://www.aligntech.com

Financial Performance

In 2025, Align Technology's revenue was $4.03 billion, an increase of 0.90% compared to the previous year's $4.00 billion. Earnings were $410.35 million, a decrease of -2.61%.

Analyst Summary

According to 11 analysts, the average rating for ALGN stock is "Buy." The 12-month stock price target is $192.4, which is an increase of 12.78% from the latest price.

Price Target

$192.4

(12.78% upside)

Analyst Consensus: Buy